| No. of patients (%) | Mean (range) (median) |
---|---|---|
Age at initial diagnosis (years) |  | 63.0 ± 6.9 (46.7–78.8) |
Initial Gleason score |  | 7 ± 1 (4–9) |
Initial PSA level (ng/ml) |  | 22.46 ± 55.48 (1.85–378.2) (11.2) |
Pathologic tumor stage | ||
 T2N0 | 23 (51) |  |
 T2N1 | 1 (2) |  |
 T2Nx | 1 (2) |  |
 T3N0 | 8 (18) |  |
 T3N1 | 9 (20) |  |
 ypT3N0 | 2 (4) |  |
 ypT3N1 | 1 (2) |  |
R status | ||
 R0 | 30 (67) |  |
 R1 | 14 (31) |  |
 Rx | 1 (2) |  |
D’Amico risk classification | ||
 High risk | 39 (87) |  |
 Intermediate risk | 4 (9) |  |
 Low risk | 2 (4) |  |